DEA Schedule CV
Strength
20 mg/mL
Manufacturer
Ascend Laboratories, LLCNDC
67877045747
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Last Updated
4/22/2026
Active Ingredients
PREGABALINApproval Type
Generic (ANDA)
FDA Application
ANDA207623On Market Since
7/21/2019
Related Drugs
Same classification
No related drugs found.